Core Insights - OMRON Corporation is set to release its quarterly earnings on November 7, 2025, with expected earnings per share of $0.27 and revenue of $1.29 billion [1][6] Financial Metrics - The company has a price-to-earnings (P/E) ratio of 27.25, indicating investor confidence in future growth [2][6] - The price-to-sales ratio stands at 1.10, suggesting the market values the company slightly above its sales [2] - OMRNF's enterprise value to sales ratio is 1.17, reflecting a total valuation slightly higher than its revenue [3] - The enterprise value to operating cash flow ratio is 14.92, indicating the company's valuation in relation to its cash flow from operations [3] - The earnings yield is 3.67%, providing insight into the return on investment for shareholders [4] - A debt-to-equity ratio of 0.27 reflects a low level of debt, suggesting financial stability [4] - The current ratio of 2.34 indicates a strong ability to cover short-term liabilities with short-term assets [4] Strategic Developments - OMRON Ventures has invested in Sky Labs to expand global business operations and enhance strategic alliances, particularly in chronic disease prevention [5][6]
OMRON Corporation (OTC:OMRNF) Quarterly Earnings Preview
Financial Modeling Prep·2025-11-07 15:00